A new oncolytic Vacciniavirus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2019-000415
PubMed Identifier: 32217766
Publication URI: http://europepmc.org/abstract/MED/32217766
Type: Journal Article/Review
Volume: 8
Parent Publication: Journal for immunotherapy of cancer
Issue: 1
ISSN: 2051-1426